Last reviewed · How we verify
NCT03045874
Community Partnership for Healthy Sleep
trial in Pediatric Sleep in 83 participants. Completed in 30 May 2019.
30 May 2019
Quick facts
| Lead sponsor | Yale University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 83 |
| Start date | 23 February 2017 |
| Primary completion | 30 May 2019 |
| Estimated completion | 30 May 2019 |
| Sites | 1 location across United States |
Conditions studied
- Pediatric Sleep — all drugs for Pediatric Sleep →
Sponsor
Yale University
Who can join
18 and older, any sex, with Pediatric Sleep. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to conduct community-engaged research (CEnR) with families and pediatric providers caring for the children in those families to address the following specific aims: 1. Examine parents' knowledge and perceptions about their 6-36 month old children's sleep and objective characteristics of sleep, including (1a) self-reported and actigraph-recorded characteristics of sleep, sleep habits, and difficulty; (1b) the contributions of sleep habits and individual, family, community, cultural/social, and health-related factors to sleep characteristics and sleep difficulty; (1c) consequences of sleep difficulty; (1d) successful and unsuccessful strategies used to promote children's sleep and sleep habits; (1e) preferences regarding sleep promotion interventions for their children; and perceptions of the optimal timing to begin sleep promotion intervention 2. Examine pediatric primary care providers' perceptions about (2a) the importance of sleep and sleep habits for 6-36 month old children; (2b) factors that contribute to sleep habits and sleep difficulty; (2c) successful and unsuccessful approaches to promote healthy sleep habits, adequate duration and good quality sleep and assessment and management of sleep difficulty in young children within the context of their families; and (2c) barriers, facilitators, and preferences regarding sleep-promoting interventions for families with young children; 3. Collaborate with families and providers to use the information obtained in Aims 1 and 2 to develop and refine a feasible, relevant, and acceptable sleep promotion program, including procedures, protocols, patient materials, intervention fidelity plans, and delivery methods.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Sleep health in young children living with socioeconomic adversity.
Ordway MR, Sadler LS, Jeon S, O'Connell M, et al · · 2020 · cited 22× · PMID 32306413 · DOI 10.1002/nur.22023 -
Perspectives on Sleep from Multiethnic Community Parents, Pediatric Providers, and Childcare Providers.
Sadler LS, Banasiak N, Canapari C, Crowley AA, et al · · 2020 · cited 11× · PMID 32282623 · DOI 10.1097/dbp.0000000000000799 -
Community partnership for healthy sleep: Research protocol.
Redeker NS, Ordway MR, Banasiak N, Caldwell B, et al · · 2018 · cited 3× · PMID 29277901 · DOI 10.1002/nur.21840
Verify or expand the search:
- PubMed search for NCT03045874
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Yale University trials
Trials by the same sponsor.
- NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
- NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
- NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
- NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
- NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03045874 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yale University
- Last refreshed: 5 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03045874.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing